Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR

Journal of Virological Methods

Volumn 108, Issue 1, 2003, Pages 49-58

  Cook, W James ^a   Green, Kathy A ^a   Obar, Joshua J ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

BM5def; BM5eco; gag RNA; LP BM5 MuLV; Murine immunodeficiency; Real time RT PCR

Indexed keywords

CD40 ANTIGEN; GAG PROTEIN; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RODENT DISEASE; SPLEEN; VIRUS CONCENTRATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION; GENES, GAG; HELPER VIRUSES; LEUKEMIA VIRUS, MURINE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPLEEN; VIROLOGY;

MURINAE; MURINE LEUKEMIA VIRUS; TRIXIS; UNIDENTIFIED RETROVIRUS;

EID: 0037360465     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00256-2     Document Type: Article

References (45)

1. Ahonen C.L., Manning E.M., Erickson L.D., O'Connor B.P., Lind E.F., Pullen S.S., Kehry M.R., Noelle R.J. The CD40-Traf6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat. Immunol. 3:2002;451-456.
2. Aziz D.C., Hanna Z., Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature (London). 338:1989;505-508.
3. Brudevi B., Weinstock D. Fluorogenic RT-PCR assay (TaqMan) for detection and classification of bovine viral diarrhea virus. Vet. Microbiol. 83:2001;1-10.
4. Buller R.M.L., Yetter R.A., Fredrickson T.N., Morse H.C. III. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61:1987;383-387.
5. Cerny A.A., Hugin W., Hardy R.R., Hayakawa K., Zinkernagel R.M., Makino M., Morse H.C. III. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:1990;315-320.
6. Chattopadhyay S.K., Morse H.C. III, Makino M., Ruscetti S.K., Hartley J.W. A defective virus is associated with induction of a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Proc. Natl. Acad. Sci. USA. 86:1989;3862-3866.
7. Chattopadhyay S.K., Sengupta D.N., Fredrickson T.N., Morse H.C. III, Hartley J.W. Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol. 65:1991;4232-4241.
8. Coffin J.M. Retroviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M., et al. Fundamental Virology. 3rd ed. 1996;763-843 Lippincott-Raven Publishers, Philadelphia, PA.
9. Gazzinelli R.T., Giese N.A., Morse H.C. III. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:1994;2199-2208.
10. + T cells. J. Virol. 68:1994;5819-5824.
11. Green K.A., Crassi K.M., Laman J.D., Schoneveld A., Strawbridge R.R., Foy T.M., Noelle R.J., Green W.R. Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J. Virol. 70:1996;2569-2575.
12. Green K.A., Noelle R.J., Green W.R. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS. Virology. 241:1998;260-268.
13. Green K.A., Noelle R.J., Durell B.G., Green W.R. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. J. Virol. 75:2001;3581-3589.
14. Hamelin-Bourassa D., Skamene E., Gervais F. Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2. Immunogenetics. 30:1989;266-272.
15. Hartley J.W., Fredrickson T.N., Yetter R.A., Makino M., Morse H.C. III. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1989;1223-1230.
16. Hartley J.W., Wolford N.K., Old L.J., Rowe W.P. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. USA. 74:1977;789-792.
17. Hempel D.M., Smith K.A., Claussen K.A., Perricone M.A. Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR. J. Immunol. Meth. 259:2002;129-138.
18. Huang M., Simard C., Jolicoeur P. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science. 246:1989;1614-1617.
19. Huang M., Simard C., Kay D.G., Jolicoeur P. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:1991;6562-6571.
20. Huang M., Simard C., Jolicoeur P. Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus. J. Virol. 66:1992;2398-2406.
21. Huang M., Takac M., Kozak C., Jolicoeur P. The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells. J. Virol. 69:1995;4069-4078.
22. Jolicoeur P. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study AIDS pathogenesis. FASEB. 5:1991;2398-2405.
23. Klinken S.P., Fredrickson T.N., Hartley J.W., Yetter R.A., Morse H.C. III. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140:1988;1123-1131.
24. Klinman D.M., Morse H.C. III. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1989;1144-1149.
25. Kubo Y., Kakimi K., Higo K., Kobayashi H., Ono T., Iwama Y., Kuribayashi K., Kiai H., Adachi A., Ishimoto A. Possible origin of murine AIDS (MAIDS) virus: conversion of an endogenous retroviral p12 gag sequence to a MAIDS-inducing sequence by frameshift mutations. J. Virol. 70:1996;6405-6409.
26. Lee J.S., Giese N.A., Elkins K.L., Yetter R.A., Holmes K.L., Hartley J.W., Morse H.C. III. Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice. J. Virol. 69:1988;4182-4188.
27. Legrand E., Daculsi R., Duplan J.F. Characteristics of the cell populations involved in extrathymic lymphosarcoma induced in C57BL/6 mice by RadLV-RS. Leuk. Res. 5:1981;223-233.
28. Lewin S.R., Vesanen M., Kostrikis L., Hurley A., Duran M., Zhang L., Ho D.D., Markowitz M. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J. Virol. 73:1999;6099-6103.
29. Lowy D.R., Rands E., Chattopadhyay S.K., Garon C.F., Hager G.L. Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc. Natl. Acad. Sci. USA. 77:1980;614-618.
30. Makino M., Morse H.C. III, Fredrickson T.N., Hartley J.W. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 144:1990;4347-4355.
31. Makino M., Chattopadhyay S.K., Hartley J.W., Morse H.C. III. Analysis of the role of CD8+ T cells in resistance to murine AIDS in A/J mice. J. Immunol. 149:1992;1702-1706.
32. Martell M., Gomez J., Esteban J.I., Sauleda S., Quer J., Cabot B., Esteban R., Guardia J. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:1999;327-332.
33. Morse H.C. III, Yetter R.A., Via C.S., Hardy R.R., Cerny A., Hayakawa K., Hugin A.W., Miller M.W., Homes K.L., Shearer G.M. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 143:1989;844-850.
34. Morse H.C. III, Chattopadhyay S.K., Makino M., Fredrickson T.N., Ambros H.W., Hartley J.W. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS. 6:1992;607-621.
35. Mosier D.E., Yetter R.A., Morse H.C. III. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:1985;766-784.
36. Mosier D.E., Yetter R.A., Morse H.C. III. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1987;1732-1742.
37. Overbergh L., Valckx D., Waer M., Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine. 11:1999;305-312.
38. Pattengale P.K., Taylor C.R., Twomey P., Hill S., Jonasson J., Beardsley T., Haas M. Immunopathology of B cell lymphomas induced in C57BL/6 mice by dual tropic murine leukemia virus (MuLV). Am. J. Pathol. 107:1982;362-377.
39. Rowe W.P., Pugh W.E., Hartley J.W. Plaque assay techniques for murine leukemia viruses. Virology. 42:1970;1136-1139.
40. Simard C., Klein S.J., Mak T., Jolicoeur P. Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus. J. Virol. 71:1997;3013-3022.
41. Trottier M., Schlitt B.P., Lipton H.L. Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR. J. Virol. Meth. 103:2002;89-99.
42. User Bulletin No. 2, 1997. ABI PRISM 7700 Sequence Detection System, Revision A, pp. 11-13.
43. Wen S.F., Xie L., McDonald M., Digiacomo R., Chang A., Gurnani M., Shi B., Liu S., Indelicato S.R., Hutchins B., Nielsen L. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Cancer Gene Ther. 7:2000;1469-1480.
44. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:1988;623-635.
45. Yu P., Morawetz R.A., Chattopadhyay S., Makino M., Kishimoto T., Kikutani H. CD40-deficient mice infected with the defective murine leukemia virus LP-BM5def do not develop murine AIDS but produce IgE and IgG1 in vivo. Eur. J. Immunol. 29:1999;615-625.